Search
All Clinical Trials in Canada
A listing of 3904 clinical trials actively recruiting volunteers for paid trials and research studies in various therapeutic areas.
1633 - 1644 of 3904
Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy
Recruiting
Temporal lobe epilepsy (TLE) is a common type of epilepsy and one of the most likely to not be controlled by medication. For patients who do not respond to medication, surgery can result in a cure of seizures. Given the fact that around 50% of patients who undergo surgery are seizure free at 10 years there is a need to improve the understanding of what factors best predict surgical outcomes in order to improve our ability to select candidates for surgery.
The demonstration of abnormalities in t... Read More
Gender:
ALL
Ages:
Between 18 years and 64 years
Trial Updated:
05/02/2025
Locations: Peter S. Allen MRI Unit, Edmonton, Alberta
Conditions: Epilepsy, Temporal Lobe
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
Recruiting
Men with prostate cancer and their family caregivers face many physical and emotional challenges from the cancer itself and its treatment(s), which often lead to high anxiety. The pandemic has highlighted the importance of protecting our physical and mental health, and the complex responsibilities that caregivers have in supporting their loved ones. To improve the health of men with prostate cancer and of their caregivers, the research team developed TEMPO: a self-directed Tailored, wEb-based, p... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/01/2025
Locations: St. Mary's Research Centre, Montreal, Quebec +1 locations
Conditions: Cancer of the Prostate, Anxiety
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Recruiting
Crohn's disease (CD) is a long-lasting condition causing inflammation that can affect any part of the gut. The purpose of this study is to evaluate the efficacy and safety of TAK-279 versus placebo in participants with moderately to severely active Crohn's disease (CD). The main aim of this study is to learn if the 3 different doses of TAK-279 reduce bowel inflammation and ulcers in the bowel compared to the placebo after 12 weeks of treatment. Another aim is to compare any medical problems that... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
04/30/2025
Locations: GastroIntestinal BioSciences, Los Angeles, California +196 locations
Conditions: Crohn's Disease
Real-world Effects of Using Intermittently Scanned Continuous Glucose Monitoring and Pharmacist-led Coaching on the Management of Type 2 Diabetes Among Adults Not Using Insulin (REAL isCGM T2D)
Recruiting
The goal of this prospective study is to evaluate diabetes outcomes after initiating second generation intermittently scanned continuous glucose monitoring (isCGM) plus one pharmacist consultation session compared with capillary blood glucose (CBG) monitoring among insulin-naïve adults with type 2 diabetes (T2D) in a specialist endocrinology clinical setting in Canada.
Primary Outcome - To evaluate change in HbA1c at 3-6 months follow-up after initiating isCGM plus one pharmacist consultation (... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/30/2025
Locations: LMC Diabetes & Endocrinology Ltd., Toronto, Ontario
Conditions: Type 2 Diabetes
Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS)
Recruiting
Antenatal corticosteroids (ACS) reduce the risks of neonatal death and morbidities in preterm infants, such as respiratory distress syndrome.
The standard of care for pregnant people at risk of preterm birth includes 2 doses of Celestone (for a total of 24 mg in Canada, or 22.8 mg in Australia) to accelerate fetal lung maturity.
The investigators plan to conduct a randomized controlled trial to determine whether half the usual dose (12 mg in Canada, or 11.4 mg in Australia) of Celestone is non... Read More
Gender:
FEMALE
Ages:
Between 18 years and 55 years
Trial Updated:
04/30/2025
Locations: University of Calgary, Cumming School of Medicine, Calgary, Alberta +23 locations
Conditions: Preterm Birth, Premature Birth, Complication of Prematurity, Obstetric Labor, Premature, Pregnancy Complications
Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation
Recruiting
The purpose of this trial is to test whether clients of Sun Life are willing to join in a quit smoking program that offers counselling and tobacco cessation products to all participants over a 12-month period. The study team will track the safety and usage of 3 types of cessation products as well as the effectiveness of a virtual pharmacy (i.e. cessation products delivered to participants directly from a pharmacy) over a 12-week treatment period.
The purpose of this study is to look at 3 approv... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/30/2025
Locations: University of Ottawa Heart Institute, Ottawa, Ontario
Conditions: Tobacco
Effect of Switching From Intermittently Scanned to Real-time Continuous Glucose Monitoring on Diabetes Management in Adults With Type 2 Diabetes (Switch CGM T2D)
Recruiting
The goal of this prospective study is to evaluate diabetes outcomes and patient experience following a switch from second generation intermittently scanned continuous glucose monitor (isCGM) to real-time continuous glucose monitor (rtCGM) compared with participants with continued isCGM use among adults with insulin-treated type 2 diabetes (T2D) in a specialist endocrinology clinic setting in Canada. The study aims include:
Primary outcome - Evaluate change in percent time in range (TIR) at 3-6... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/30/2025
Locations: LMC Diabetes & Endocrinology Ltd., Toronto, Ontario
Conditions: Type 2 Diabetes
"Extended" (Alternate Day) Antipsychotic Dosing
Recruiting
The study wishes to examine whether "extended" antipsychotic treatment, in this case, antipsychotic treatment every other day, is as effective as daily treatment. It is also evaluating whether there may be differences in terms of side effects.
Participants will be randomly assigned to either the treatment as usual group (i.e., taking antipsychotic daily) or the extended dosing group (i.e., taking antipsychotic one day on, one day off). That means, like flipping a coin, there is a 50/50 chance t... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/30/2025
Locations: Centre for Addiction and Mental Health, Toronto, Ontario
Conditions: Schizophrenia and Related Disorders, Drug Administration Schedule, Drug Therapy, Antipsychotic Agents
Albumin To Enhance Recovery After Acute Kidney Injury
Recruiting
Study objectives:
To determine whether, in critically ill patients with Acute Kidney Injury requiring renal replacement therapy (AKI-RRT), randomization to receive intravenous hyperoncotic albumin 20-25% (100 mL X two doses) compared to control/placebo normal saline boluses (100 mL X two doses) given during RRT sessions, leads to:
1. An increase in organ support-free days (primary outcome) at 28 days following randomization; and
2. An increase in RRT-free days (principal secondary outcome) at... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/30/2025
Locations: The Governors of the University of Calgary, Calgary, Alberta +15 locations
Conditions: Acute Kidney Injury, Renal Replacement Therapy, Hypotension, Critical Illness
Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)
Recruiting
Limit: 5000 characters. Psilocybin, the chemical component of "magic mushrooms", has been administered with psychotherapy in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. In healthy volunteers, the psychedelic effects of psilocybin have been shown to be blocked by administration of certain medications such as risperidone.
The purpose of this study is to use an established SV2A radiotracer produced at our Centre to determine the feasibility of inte... Read More
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
04/30/2025
Locations: Centre for Addiction and Mental Health, Toronto, Ontario
Conditions: Treatment Resistant Depression
Biofeedback in Idiopathic Infantile Nystagmus Syndrome
Recruiting
Active eye movement control training, an old and still most prevalent intervention in low vision rehabilitation (LVR) was never used in nystagmus clinically.
Biofeedback training (BT) is the latest and newest technique for oculomotor control training in cases with low vision when using available modules in the new microperimetry instruments. Laboratory studies in the literature highlighted positive benefits from using BT in nystagmus cases. The purpose of this study is to assess systematically... Read More
Gender:
ALL
Ages:
Between 5 years and 17 years
Trial Updated:
04/29/2025
Locations: CNIB, Toronto, Ontario
Conditions: Low Vision in Children
Vascular Complications in Children From T1D Diagnosis
Recruiting
Cardiovascular disease is a complication of type 1 diabetes (T1D), a life-long disease, usually diagnosed in childhood. The goal of this project is to determine the timing and factors leading to vascular damage in children from T1D diagnosis.
Gender:
ALL
Ages:
Between 8 years and 18 years
Trial Updated:
04/29/2025
Locations: Endocrine and Diabetes Unit, BC Children's Hospital, Vancouver, British Columbia
Conditions: Type 1 Diabetes, Cardiovascular Complications, Child, Adolescent
1633 - 1644 of 3904
